Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Security class unavailable · CUSIP: 690469101
Event date: 2019-10-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,531,996
- Percent of class
- 15.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-19-000082
- Form type
- SC 13G
- Filer
- Ovid Therapeutics Inc.
- CIK
- CIK 1636651
- Filed
- Nov 22, 2019
- Reporting period
- Oct 08, 2019
- Description
- Schedule 13G beneficial ownership